Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, U.S.A.
Department of Cancer Biology, Wake Forest School of Medicine, Medical Center Blvd, Winston Salem, NC, 27157.
Front Biosci (Landmark Ed). 2017 Jun 1;22(10):1805-1829. doi: 10.2741/4573.
Malignant brain tumors and brain metastases are highly aggressive diseases that are often resistant to treatment. Consequently, the current prognosis of patients with brain tumors and metastases is dismal. Activated microglia and macrophages are often observed in close proximity to or within the malignant tumor masses, suggesting that microglia/macrophages play an important role in brain tumor progression. Microglia, being resident macrophages of the central nervous system, form a major component of the brain immune system. They exhibit anti-tumor functions by phagocytosis and the release of cytotoxic factors. However, these microglia/macrophages can be polarized into becoming tumor-supportive and immunosuppressive cells by certain tumor-derived soluble factors, thereby promoting tumor maintenance and progression. The activated microglia/macrophages also participate in the process of tumor angiogenesis, metastasis, dormancy, and relapse. In this review, we discuss the recent literature on the dual roles of microglia/macrophages in brain tumor progression. We have also reviewed the effect of several well-known microglia/macrophages-derived molecules and signals on brain tumor progression and further discussed the potential therapeutic strategies for targeting the pro-tumor and metastatic functions of microglia/macrophages.
恶性脑肿瘤和脑转移瘤是高度侵袭性的疾病,通常对治疗有抗性。因此,目前脑肿瘤和转移瘤患者的预后较差。在恶性肿瘤块附近或内部常观察到活化的小胶质细胞和巨噬细胞,这表明小胶质细胞/巨噬细胞在脑肿瘤进展中起重要作用。小胶质细胞是中枢神经系统的固有巨噬细胞,构成了大脑免疫系统的主要成分。它们通过吞噬作用和释放细胞毒性因子发挥抗肿瘤功能。然而,某些肿瘤衍生的可溶性因子可将这些小胶质细胞/巨噬细胞极化为支持肿瘤和免疫抑制细胞,从而促进肿瘤的维持和进展。活化的小胶质细胞/巨噬细胞也参与肿瘤血管生成、转移、休眠和复发的过程。在这篇综述中,我们讨论了小胶质细胞/巨噬细胞在脑肿瘤进展中的双重作用的最新文献。我们还回顾了几种著名的小胶质细胞/巨噬细胞衍生分子和信号对脑肿瘤进展的影响,并进一步讨论了针对小胶质细胞/巨噬细胞促肿瘤和转移功能的潜在治疗策略。
Front Biosci (Landmark Ed). 2017-6-1
Neuro Oncol. 2010-7-28
Int J Mol Sci. 2018-2-1
Arkh Patol. 2015
Exp Hematol Oncol. 2024-1-16
Cell Oncol (Dordr). 2016-10-20
Cancer Res. 2014-12-15